Famon Awal Bros Sedaya Tbk PT
IDX:PRAY
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
P/FCFE
Price to Free Cash Flow to Equity (P/FCFE) ratio compares a company`s market value to the free cash flow available to its shareholders. It`s similar to the P/OCF ratio but more precise, since it accounts for capital expenditures deducted from operating cash flow.
Price to Free Cash Flow to Equity (P/FCFE) ratio compares a company`s market value to the free cash flow available to its shareholders. It`s similar to the P/OCF ratio but more precise, since it accounts for capital expenditures deducted from operating cash flow.
Valuation Scenarios
If P/FCFE returns to its Industry Average (56.7), the stock would be worth Rp-445.41 (159% downside from current price).
| Scenario | P/FCFE Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | -95.6 | Rp750 |
0%
|
| Industry Average | 56.7 | Rp-445.41 |
-159%
|
| Country Average | 12.6 | Rp-99.13 |
-113%
|
Forward P/FCFE
Today’s price vs future free cash flow to equity
Peer Comparison
| Market Cap | P/FCFE | P/E | ||||
|---|---|---|---|---|---|---|
| ID |
F
|
Famon Awal Bros Sedaya Tbk PT
IDX:PRAY
|
10.5T IDR | -95.6 | 49.5 | |
| US |
|
HCA Healthcare Inc
NYSE:HCA
|
97.1B USD | 10.5 | 14.3 | |
| SA |
|
Dr Sulaiman Al-Habib Medical Services Group Co
SAU:4013
|
98B SAR | 93.8 | 40.8 | |
| ZA |
N
|
Netcare Ltd
JSE:NTC
|
23.7B ZAR | 14.5 | 14.1 | |
| MY |
I
|
IHH Healthcare Bhd
KLSE:IHH
|
77.9B MYR | 34.4 | 37.1 | |
| ZA |
L
|
Life Healthcare Group Holdings Ltd
JSE:LHC
|
17.7B ZAR | 9.5 | 4.6 | |
| BR |
|
Rede D'Or Sao Luiz SA
BOVESPA:RDOR3
|
84.7B BRL | 107.3 | 18.1 | |
| US |
|
Tenet Healthcare Corp
NYSE:THC
|
15.4B USD | 9.5 | 11.4 | |
| CN |
A
|
Aier Eye Hospital Group Co Ltd
SZSE:300015
|
100.5B CNY | 24.1 | 29.8 | |
| IN |
|
Apollo Hospitals Enterprise Ltd
NSE:APOLLOHOSP
|
1.1T INR | 43.2 | 60.8 | |
| US |
|
Ensign Group Inc
NASDAQ:ENSG
|
10.8B USD | 29.4 | 30.9 |
Market Distribution
| Min | 0.7 |
| 30th Percentile | 8.6 |
| Median | 12.6 |
| 70th Percentile | 24 |
| Max | 1 806 198.3 |
Other Multiples
Famon Awal Bros Sedaya Tbk PT
Glance View
PT Famon Awal Bros Sedaya Tbk operates as a holding company with interest in hospital operation. The company is headquartered in Jakarta Pusat, Dki Jakarta and currently employs 5,157 full-time employees. The company went IPO on 2022-11-08. The firm is engaged in private hospital activities and other management consulting. The firm operates approximately 15 hospitals across various cities in Indonesia. Its geographical segments include Jawa, Kalimantan dan and Sulawesi, and Sumatera. The Company’s subsidiaries include PT Famon Global Medika, PT Fortuna Anugerah Sehat, PT Fortuna Anugerah Medika, PT Fortuna Graha Sentosa, PT Fortuna Medika Sejahtera, PT Fortuna Prima Sentosa, PT Fortuna Sentosa Sejahtera, PT Fortuna Griya Medika, PT Fortuna Selamat Sejahtera, PT Global Prime System and PT Kasih Karunia Alkesindo, and others.
